3/2024

Limberg flap for previously recurrent complex sacrococcygeal pilonidal sinus surgeries

J. Aljarrah, I. Alrawashdeh, M. Debian, T. Harahsheh, A. Aldurgham, L. Alshehabat, A. Alrabadi, A. Abu Anzeh, T. Alhalahlah, M. Abual’anaz

Department of General Surgery, Jordanian Royal Medical Services, Amman, Jordan

Summary

Objective: Limberg flap, is a rotational rhomboid flap. A procedure done for people who have either complex or recurrent pilonidal disease. This study has been performed to determine effects of the Limberg flap for sacrococcygeal pilonidal sinus, regarding the wound infection rate, seroma formation, postoperative pain relief, recurrence rates, return to work, its cosmetic final result and patients’ satisfaction. Methods: A total of 10 patients were operated from January 2022 to March 2023. Patients were selected according to the disease complexity and recurrence, so that the patients selected were classified as complex and at least of a second recurrence of the disease. Results: Patients successfully underwent surgery, with mild to moderate postoperative pain, stayed in hospital for 3 days in average, returned to work after 6 weeks, with 5 patients having flap oedema, 1 patient had wound infection, no one had flap necrosis, and there were no recurrences so far for an average follow-up time of about 3 months. Patients with flap oedema took 2–3 weeks to heal with regular dressing only. Patient satisfaction and final cosmetic result were well accepted. Limberg flap for sacrococcygeal pilonidal sinus was found very useful in terms of recurrences. Conclusion: Better patients’ acceptance and satisfaction despite the increased risk in postoperative pain, infection rates, and longer return to work in comparison to the open procedures.

Key words

limberg flap – sacrococcygeal pilonidal sinus – wound infection – postoperative pain – recurrence – flap oedema

Aljarrah M, Alrawashdeh I, Debian M et al. Limberg flap for previously recurrent complex sacrococcygeal pilonidal sinus surgeries. Acta Chir Plast 2024; 66 (3): 120–123.

Are you a healthcare professional?

I am a professional pursuant to Act No. 2a, Rule 40/1995 Coll., describing commercial advertising regulations, as amended; I am therefore authorized to prescribe or sell or distribute medicinal products.